Reason for request
Extension of indication
Clinical Benefit
| Substantial |
Substantial in type 1 diabetes in children aged 2 to 5 years. |
Clinical Added Value
| no clinical added value |
LANTUS provides no improvement in actual benefit (IAB V, non-existent) in the management of children aged 2 to 5 years with type 1 diabetes. |
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
9E330XYntfPMm8KE
Listen
